AQR Capital Management
IMGN

AQR Capital Management’s Immunogen Inc IMGN Stock Holding History

AQR Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-77,523
Closed -$2.3M – 2535
2023
Q4 		$2.3M Sell
77,523
-48,114
-38% -$958K ﹤0.01% 1286
2023
Q3 		$1.99M Buy
125,637
+99,725
+385% +$1.66M ﹤0.01% 1327
2023
Q2 		$489K Buy
25,912
+1,134
+5% +$13.4K ﹤0.01% 1795
2023
Q1 		$95.1K Sell
24,778
-1,398
-5% -$5.96K ﹤0.01% 2118
2022
Q4 		$130K Hold
26,176
– – ﹤0.01% 2121
2022
Q3 		$125K Sell
26,176
-4,216
-14% -$22.2K ﹤0.01% 2094
2022
Q2 		$137K Sell
30,392
-209,929
-87% -$912K ﹤0.01% 2051
2022
Q1 		$1.14M Buy
240,321
+47,763
+25% +$264K ﹤0.01% 1477
2021
Q4 		$1.43M Buy
192,558
+1,621
+0.8% +$10.1K ﹤0.01% 1375
2021
Q3 		$1.08M Sell
190,937
-27,416
-13% -$158K ﹤0.01% 1493
2021
Q2 		$1.44M Buy
218,353
+83,005
+61% +$579K ﹤0.01% 1406
2021
Q1 		$1.1M Buy
135,348
+44,932
+50% +$367K ﹤0.01% 1515
2020
Q4 		$583K Sell
90,416
-146,113
-62% -$852K ﹤0.01% 1731
2020
Q3 		$852K Sell
236,529
-110,785
-32% -$447K ﹤0.01% 1496
2020
Q2 		$1.6M Buy
347,314
+69,186
+25% +$294K ﹤0.01% 1268
2020
Q1 		$948K Buy
278,128
+41,880
+18% +$183K ﹤0.01% 1358
2019
Q4 		$1.21M Buy
236,248
+34,164
+17% +$116K ﹤0.01% 1451
2019
Q3 		$489K Buy
202,084
+136,461
+208% +$362K ﹤0.01% 1763
2019
Q2 		$142K Sell
65,623
-106,021
-62% -$251K ﹤0.01% 2015
2019
Q1 		$465K Buy
171,644
+101,583
+145% +$440K ﹤0.01% 1835
2018
Q4 		$336K Sell
70,061
-1,491
-2% -$9.05K ﹤0.01% 1929
2018
Q3 		$678K Buy
71,552
+1,701
+2% +$16.4K ﹤0.01% 1843
2018
Q2 		$680K Sell
69,851
-11,690
-14% -$123K ﹤0.01% 1874
2018
Q1 		$858K Sell
81,541
-313,416
-79% -$3.1M ﹤0.01% 1729
2017
Q4 		$2.53M Buy
394,957
+333,455
+542% +$2.06M ﹤0.01% 1279
2017
Q3 		$470K Sell
61,502
-65,772
-52% -$437K ﹤0.01% 1962
2017
Q2 		$905K Buy
+127,274
New +$582K ﹤0.01% 1707
2017
Q1 		– Sell
-134,939
Closed -$275K – 2266
2016
Q4 		$275K Sell
134,939
-30,494
-18% -$61.2K ﹤0.01% 2074
2016
Q3 		$444K Buy
+165,433
New +$481K ﹤0.01% 1980
2016
Q2 		– Sell
-28,467
Closed -$243K – 2275
2016
Q1 		$243K Sell
28,467
-104,928
-79% -$888K ﹤0.01% 2066
2015
Q4 		$1.81M Buy
133,395
+16,212
+14% +$200K ﹤0.01% 1292
2015
Q3 		$1.13M Buy
+117,183
New +$1.71M ﹤0.01% 1376
2015
Q2 		– Sell
-23,000
Closed -$206K – 2271
2015
Q1 		$206K Hold
23,000
– – ﹤0.01% 2009
2014
Q4 		$140K Sell
23,000
-127
-0.5% -$1.16K ﹤0.01% 2412
2014
Q3 		$245K Hold
23,127
– – ﹤0.01% 2260
2014
Q2 		$274K Hold
23,127
– – ﹤0.01% 2247
2014
Q1 		$345K Hold
23,127
– – ﹤0.01% 2205
2013
Q4 		$339K Hold
23,127
– – ﹤0.01% 2249
2013
Q3 		$394K Hold
23,127
– – ﹤0.01% 2088
2013
Q2 		$384K Buy
+23,127
New +$375K ﹤0.01% 1994

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AQR Capital Management's IMGN Position: Q1 2024 in Review

AQR Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 77,523 shares — an estimated $2.3M sold.

AQR Capital Management first reported a position in IMGN in Q2 2013 and held it in 40 quarters. The position peaked at $2.53M in Q4 2017. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • AQR Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • AQR Capital Management sold 77,523 Immunogen Inc shares in Q1 2024, an estimated $2.3M.
  • AQR Capital Management first reported a position in Immunogen Inc in Q2 2013 and held it in 40 quarters.
  • AQR Capital Management's Immunogen Inc position peaked at $2.53M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on AQR Capital Management's 13F filing for Q1 2024, filed 15 May 2024.